Spinal astroglial cannabinoid receptors control pathological tremor

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Cannabinoids are known to reduce tremors in motor disorders.
• The precise cellular mechanisms underlying this effect, particularly within the spinal cord, remain incompletely understood.

Purpose of the Study:

• To elucidate the role of spinal astrocytes and cannabinoid receptors in mediating the anti-tremor effects of cannabinoids.
• To investigate the signaling pathways involved in cannabinoid-induced tremor reduction.

Main Methods:

• Intrathecal administration of the cannabinoid analog WIN55,212-2 in a mouse model of essential tremor.
• Electrophysiological recordings in spinal cord slices to analyze neuronal and astrocytic activity.
• Genetic manipulation to knock out cannabinoid CB1 receptors specifically in astrocytes.

Main Results:

• WIN55,212-2 administration significantly reduced tremor in the mouse model.
• Endocannabinoids activate astrocytic cannabinoid receptors, leading to increased intracellular calcium, purine release, and inhibition of excitatory neurotransmission.
• The anti-tremor effect of WIN55,212-2 was abolished in mice with astrocyte-specific CB1 receptor knockout.

Conclusions:

• Cannabinoids exert their anti-tremor effects through the activation of cannabinoid receptors located on spinal astrocytes.
• This action involves a signaling cascade initiated by endocannabinoid release and mediated by purinergic signaling and neurotransmission inhibition.
• Targeting spinal astrocytes represents a potential therapeutic strategy for managing tremors in motor disorders.